Drug Type Small molecule drug |
Synonyms Nolatrexed, Orataq, Thymitaq + [4] |
Target |
Mechanism TYMS inhibitors(Thymidylate synthase inhibitors) |
Therapeutic Areas |
Active Indication- |
Inactive Indication |
Originator Organization |
Active Organization- |
Inactive Organization |
Drug Highest PhaseDiscontinuedNDA/BLA |
First Approval Date- |
RegulationOrphan Drug (US) |
Molecular FormulaC14H14Cl2N4OS |
InChIKeyPJKVJJYMWOCLIJ-UHFFFAOYSA-N |
CAS Registry152946-68-4 |
KEGG | Wiki | ATC | Drug Bank |
---|---|---|---|
- | - | - |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Hepatocellular Carcinoma | NDA/BLA | CN | 19 Jan 2015 | |
Nasopharyngeal Neoplasms | NDA/BLA | CN | 19 Jan 2015 | |
Unresectable Hepatocellular Carcinoma | Phase 3 | US | 01 Sep 2000 | |
Unresectable Hepatocellular Carcinoma | Phase 3 | CA | 01 Sep 2000 | |
Unresectable Hepatocellular Carcinoma | Phase 3 | PR | 01 Sep 2000 | |
Liver Cancer | Phase 3 | US | - | |
Liver Cancer | Phase 3 | CA | - | |
Liver Cancer | Phase 3 | - | - | |
Liver Cancer | Phase 3 | ZA | - | |
Locally Advanced Head and Neck Squamous Cell Carcinoma | Phase 2 | CN | 16 Apr 2024 |
Phase 3 | 445 | mfwqrfdnfr(hnlknvkjnp) = veabsjlhnp gbsssvivty (tuzoegmabm ) View more | Negative | 20 Jul 2007 | |||
Doxorubicin | mfwqrfdnfr(hnlknvkjnp) = qdcarlyzhn gbsssvivty (tuzoegmabm ) View more | ||||||
Phase 1 | 8 | cpugrmdynq(hjmxgrtrht) = dloppyqcoi tovkyabpga (ymtblqkycu, 2.86 - 6.19) | - | 01 Jun 2005 | |||
Phase 3 | 446 | gedzsfdkli(dpwlyuepdr) = ussyykvmcj adnnwbxabt (knkgqhclwa ) View more | - | 01 Jun 2005 | |||
fvbxnazzqw(xqufxaghjr) = ihwpzxcuuq gomamfwrld (jmliswykwt ) | |||||||
Phase 2 | 54 | msobrdscra(bilzwbawwk) = xvijxqiqtf ycaoovrjel (ptzozbuxip ) | - | 15 Jul 2004 | |||
msobrdscra(bilzwbawwk) = nuymxuktps ycaoovrjel (ptzozbuxip ) |